Figure 2. Clonal hematopoiesis with CSF3R mutations. (A) Percentage of cases with clonal hematopoiesis due to any gene mutation. (B) Age of individuals with or without clonal hematopoiesis due to any gene mutation. (C) Percentage of cases with clonal hematopoiesis due to CSF3R mutations. ***P = .003 compared with healthy donors. (D) Percentage of cases with clonal hematopoiesis due to mutations in genes besides CSF3R. (E) Age of patients with SCN based on the number of CSF3R mutations. (F) The CSF3R mutations, with the number of times the mutation was seen in parentheses. (G) ANC prior to G-CSF treatment. (H) The median G-CSF dose. The mean ± standard deviation is shown.
Figure 2.

Clonal hematopoiesis with CSF3R mutations. (A) Percentage of cases with clonal hematopoiesis due to any gene mutation. (B) Age of individuals with or without clonal hematopoiesis due to any gene mutation. (C) Percentage of cases with clonal hematopoiesis due to CSF3R mutations. ***P = .003 compared with healthy donors. (D) Percentage of cases with clonal hematopoiesis due to mutations in genes besides CSF3R. (E) Age of patients with SCN based on the number of CSF3R mutations. (F) The CSF3R mutations, with the number of times the mutation was seen in parentheses. (G) ANC prior to G-CSF treatment. (H) The median G-CSF dose. The mean ± standard deviation is shown.

or Create an Account

Close Modal
Close Modal